BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  BioGX and Launch Diagnostics Announce Distribution Partnership for U.K. and Ireland

  BioGX continues to expand its global presence with the announcement of a distribution partnership between BioGX’s Amsterdam-based European subsidiary, BioGX B.V., and U.K.-based distributor, Launch Diagnostics.

  February 8, 2018

   · 

  3 min read
• Business

  Perrigo to Release Fourth Quarter and Calendar Year 2017 Financial Results On February 27, 2018

  Perrigo today announced that it will release its fourth quarter and calendar year 2017 financial results on Tuesday, February 27, 2018.

  February 8, 2018

   · 

  4 min read
• Business

  Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Highlights Recent Period Activity

  At December 31, 2017, Alnylam had cash, cash equivalents and fixed income marketable securities, and restricted investments of $1.73 billion, as compared to $1.09 billion at December 31, 2016.

  February 8, 2018

   · 

  22 min read
• Drug Development

  pSivida’s Second Phase III Study for Durasert Three-Year Treatment for Posterior Segment Uveitis Maintains Positive Efficacy and Safety Profile at 12 Months

  The study involved 153 patients with posterior segment uveitis.

  February 8, 2018

   · 

  7 min read
• 

  Business

  Immunocore CEO Steps Down, Effective Immediately

  Dr Forster informed the Board of his decision earlier this week and will be replaced, in an interim capacity, by Chief Commercial Officer Andrew Hotchkiss.

  February 8, 2018

   · 

  3 min read
• Pharm Country

  UBM Release: Pharmapack Europe Award Winners 2018 21 Years Dedicated to the Industry’s Biggest Innovation

  BIOCORP, West Pharmaceutical Services, Inc. & sfm medical devices GmbH win prestigious ‘Exhibitor Innovation’

  February 8, 2018

   · 

  4 min read
• BioMidwest

  AptarGroup and Adapt Pharma Donate NARCAN Nasal Spray to Opioid Crisis Coalitions in Illinois

  AptarGroup and Adapt Pharma today announced a joint donation of 4,000 doses of NARCAN® to Illinois Governor Bruce Rauner’s Opioid Overdose Prevention and Intervention Task Force, with another 1,000 doses scheduled to go to the McHenry County Substance Abuse Coalition Friday.

  February 8, 2018

   · 

  5 min read
• Business

  Sunesis Pharmaceuticals Appoints Industry Veteran H. Ward Wolff to the Board of Directors

  Mr. Wolff most recently having served as Executive Vice President and Chief Financial Officer of Sangamo Therapeutics.

  February 8, 2018

   · 

  5 min read
• Aptose Biosciences Files New Preliminary Base Shelf Prospectus to Replace Expired Base Prospectus

  The Preliminary Shelf Prospectus and corresponding shelf registration statement have not yet become final or effective.

  February 8, 2018

   · 

  5 min read
• Business

  Sonoma Pharmaceuticals Reports Record Total Revenue of $4.8 million for Third Quarter FY 2018 with Year over Year Product Revenue Growth of 46%

  Total revenue was $4.8 million for the third quarter as compared to $3.4 million for the same period last year.

  February 8, 2018

   · 

  15 min read